Cargando…

Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritis

BACKGROUND: Several health authorities recommend a third (booster) vaccination to protect patients with rheumatic and musculoskeletal diseases from severe COVID-19. Methotrexate has been shown to reduce the efficacy of the first and second dose of SARS-CoV-2 mRNA vaccines. So far, it remains unknown...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stahl, David, tho Pesch, Carola, Brück, Carolin, Esser, Ruth L, Thiele, Jan, Di Cristanziano, Veronica, Kofler, David M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556739/ https://www.ncbi.nlm.nih.gov/pubmed/36216409 http://dx.doi.org/10.1136/rmdopen-2022-002632

Ejemplares similares

High increase in levels of lipoprotein(a) in plasma of patients with rheumatoid arthritis after COVID‐19
por: Stahl, David, et al.
Publicado: (2022)

Truncated isoforms of GPSM2 containing the GoLoco motif region promote CD4(+) T-cell migration in SLE
por: Esser, Ruth L, et al.
Publicado: (2022)

Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination
por: Habermann, Elisa, et al.
Publicado: (2022)

Regulatory T Cells from Patients with Rheumatoid Arthritis Are Characterized by Reduced Expression of Ikaros Zinc Finger Transcription Factors
por: Dittrich-Salamon, Mara, et al.
Publicado: (2022)

Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy
por: Sidler, Daniel, et al.
Publicado: (2022)

Should we stop methotrexate or not for vaccination?
por: Durez, Patrick, et al.
Publicado: (2023)

Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses
por: Bitoun, Samuel, et al.
Publicado: (2022)

COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

Concomitant prednisone may alleviate methotrexate side-effects in rheumatoid arthritis patients
por: van der Leeuw, Matthijs S., et al.
Publicado: (2023)

Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases
por: Fragoulis, George E, et al.
Publicado: (2022)

Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies
por: Geisen, Ulf M, et al.
Publicado: (2021)

T-cell STAT3 is required for the maintenance of humoral immunity to LCMV
por: McIlwain, David R, et al.
Publicado: (2015)

Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?
por: Chen, Hsin-Hua, et al.
Publicado: (2016)

Treatment of rheumatoid arthritis in the USA: premature use of tumor necrosis factor inhibition and underutilization of concomitant methotrexate
por: O’Dell, James R, et al.
Publicado: (2018)

Dose Adjustment of Methotrexate Administered Concomitantly with Golimumab for Rheumatoid Arthritis in Japanese Real-World Clinical Settings
por: Yamairi, Fumiko, et al.
Publicado: (2020)

Management of recurrent localised bladder amyloid, has methotrexate helped?
por: Kelsey, E., et al.
Publicado: (2023)

Humoral immunity and transcriptome differences of COVID-19 inactivated vacciane and protein subunit vaccine as third booster dose in human
por: Zhang, Yuwei, et al.
Publicado: (2022)

Humoral response in Leishmaniasis
por: Conde, Luciana, et al.
Publicado: (2022)

Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study
por: Broadwell, Aaron, et al.
Publicado: (2023)

Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis
por: Salem, Heba F., et al.
Publicado: (2022)

Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms
por: Kobayashi, Mirei, et al.
Publicado: (2023)

Impact of a booster dose on SARS-CoV2 mRNA vaccine-specific humoral-, B- and T cell immunity in pediatric stem cell transplant recipients
por: Thole, Linda Marie Laura, et al.
Publicado: (2023)

Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
por: Andreica, Ioana, et al.
Publicado: (2022)

Underestimation of Staphylococcus aureus (MRSA and MSSA) carriage associated with standard culturing techniques: One third of carriers missed
por: Tsang, S. T. J., et al.
Publicado: (2018)

Methotrexate alone and methotrexate combined with etanercept in treatment of rheumatoid arthritis
por: Rexhepi, Sylejman, et al.
Publicado: (2012)

Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients
por: Schietzel, Simeon, et al.
Publicado: (2022)

Humoral and cellular immune responses in persons with rheumatoid arthritis after a third dose of mRNA COVID-19 vaccine
por: Tedeschi, Sara K., et al.
Publicado: (2023)

Acute scrotum – Torsion of the third testicle!
por: Kealey, Joshua, et al.
Publicado: (2018)

Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity
por: Calabrese, Cassandra, et al.
Publicado: (2022)

Methotrexate significantly reduces the humoral vaccination response against SARS-CoV-2 in older but not younger patients with rheumatoid arthritis
por: Feuchtenberger, Martin, et al.
Publicado: (2022)

CONCOMITANT PULMONARY MUCORMYCOSIS AND PULMONARY ASPERGILLOSIS IN A YOUNG PATIENT WITH COVID-19
por: FELDMAN, ERICA, et al.
Publicado: (2021)

Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod
por: Capuano, Rocco, et al.
Publicado: (2022)

Psoriatic flare after the concomitant administration of L-methylfolate and methotrexate
por: Nazarian, Roya S., et al.
Publicado: (2016)

Methotrexate Hepatotoxicity in Patients with Rheumatoid Arthritis
por: Sotoudehmanesh, R, et al.
Publicado: (2010)

Adherence to Methotrexate therapy in Rheumatoid Arthritis
por: Arshad, Nasim, et al.
Publicado: (2016)

Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules
por: Choi, Ju-yeon, et al.
Publicado: (2022)

BNT162b2 Third Booster Dose Significantly Increases the Humoral Response Assessed by Both RBD IgG and Neutralizing Antibodies in Renal Transplant Recipients
por: Hod, Tammy, et al.
Publicado: (2022)

Diagnosis of periprosthetic joint infections in patients who have rheumatoid arthritis: application of routine serological and synovial fluid indexes
por: Wang, Yulai, et al.
Publicado: (2023)

Incidence and Risk Factors of Hepatic Fibrosis in Psoriatic Patients Receiving Methotrexate with Concomitant Acitretin Therapy and Methotrexate Monotherapy
por: Rattanakaemakorn, Ploysyne, et al.
Publicado: (2021)

Risk factors for herpes zoster in Korean patients with rheumatoid arthritis treated with JAK inhibitor: a nested case–control study
por: Song, Yeo-Jin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mkbmgrcbiao0t3vrrgbfh7i4u6